There is no better time than now to start your journey to better health. Learn More
If Wegovy®, Ozempic®, or Zepbound® stopped working, caused severe side effects, or felt unsustainable, you have not failed—your body adapted. Discover how bariatric surgery resets your metabolic set-point permanently.
Schedule your GLP-1 Transition ConsultCall Our Office: (770) 232-9252
✓ Board-Certified Bariatric Surgeons
✓ MBSAQIP Accredited Center of Excellence
✓ Most Major Insurance Plans Accepted
GLP-1 receptor agonists like semaglutide and tirzepatide have transformed medical weight loss. However, clinical studies show that up to 15% to 20% of patients experience non-responsiveness or a hard weight loss plateau within 12 to 18 months of starting treatment.
When you lose weight rapidly on medication, your brain perceives a calorie deficit as a threat. In response, your body triggers metabolic adaptation: decreasing your baseline metabolic rate, altering satiety hormones (like ghrelin and leptin), and counteracting the medication’s effects.
While GLP-1 medications temporarily slow stomach emptying and mimic hunger hormones, metabolic surgery fundamentally resets your endocrine system for sustained, long-term results.
Key Factor | GLP-1 Medications (Semaglutide / Tirzepatide) | Bariatric Surgery (Gastric Sleeve / Bypass) |
|---|---|---|
Mechanism of Action | Temporary hormone mimicry (requires continuous lifelong medication) | Permanent biological reduction of hunger hormones (Ghrelin) |
Average Weight Loss | 15% – 20% of total body weight (plateaus at 68–72 weeks) | 50% to 70% of excess weight lost and maintained long-term |
Treatment Duration | Indefinite weekly injections (90%+ regain weight if stopped) | One-time, minimally invasive surgical procedure |
Cost & Coverage | High monthly out-of-pocket costs ($800–$1,300/mo) if uncovered | Covered by most major commercial health insurance plans |
Health Comorbidity Relief | Improves glycemic control while medication is actively used | High rates of long-term remission for Type 2 Diabetes, Sleep Apnea, GERD, and Hypertension |
At Atlanta Bariatrics, board-certified surgeons Dr. Christopher J. Hart and Dr. William H. Johnson specialize in evaluating patients who have hit a wall with weight loss medications. Surgery is not a step backward—it is the definitive clinical tool to achieve permanent metabolic health.
This procedure involves removing approximately 80% to 85% of the stomach, leaving a sleeve-shaped section. The reduced stomach size limits food intake while significantly reducing ghrelin (the hunger hormone). Because there is no rerouting of the intestines, nutrient absorption remains unchanged. Most studies show an average of 50% to 55% of excess weight remains off even 9 years after surgery. Read complete details on our Gastric Sleeve Surgery Page.
In this surgery, a small stomach pouch is created and connected directly to the small intestine, bypassing a significant portion of the stomach and the first segment of the intestine. This dual approach restricts food intake while reducing calorie absorption. Patients average about 70% loss of excess weight within the first 12 to 24 months, making it particularly effective for severe obesity, Type 2 Diabetes, and severe acid reflux (GERD). Learn more on our Gastric Bypass Surgery Page.
Choosing a surgical partner requires proven expertise, advanced technology, and compassionate long-term care. Atlanta Bariatrics is recognized as a regional leader in metabolic and bariatric surgery across Georgia.
Yes. Many of our patients transition directly from GLP-1 medications to bariatric surgery. However, because GLP-1 medications delay gastric emptying, our surgical team will provide specific instructions on when to safely stop taking your medication prior to surgery and anesthesia.
Weight loss plateaus occur due to metabolic adaptation. Over time, your body adapts to lower calorie intakes and counteracts the pharmaceutical effects of semaglutide or tirzepatide by slowing metabolic expenditure and altering hunger signaling. Bariatric surgery permanently alters stomach anatomy and hormone production to bypass this plateau.
Most major commercial health insurance plans in Georgia cover bariatric surgery for patients who meet clinical criteria. You can check your BMI and learn if you qualify by using our interactive Atlanta Bariatrics BMI Calculator. Typically, a BMI of 40 or higher qualifies you for surgery, or a BMI between 35 and 39.9 if accompanied by weight-related medical conditions such as diabetes, high blood pressure, heart disease, sleep apnea, high cholesterol, or GERD. Having a documented history on weight loss medications can strengthen your insurance approval case. Our team verifies your insurance coverage for free.
While GLP-1 medications average a 15% to 20% total body weight reduction (which is often regained if medication is stopped), bariatric surgery results in 50% to 70% excess weight loss depending on the procedure selected, with long-term maintenance proven over decades of clinical research. Explore details on both Sleeve Gastrectomy and Roux-en-Y Gastric Bypass to see expected results for each option.
Fill out the form below or call (770) 232-9252 to verify your insurance coverage and request a consultation with our Metro Atlanta bariatric surgical specialists. You can also review our Are You a Candidate? Guide to explore requirements before booking.